MiMedx Group, Inc. (MDXG)
NASDAQ: MDXG · Real-Time Price · USD
4.240
-0.120 (-2.75%)
At close: Mar 18, 2026, 4:00 PM EDT
4.280
+0.040 (0.94%)
After-hours: Mar 18, 2026, 7:18 PM EDT
MiMedx Group Employees
MiMedx Group had 808 employees as of December 31, 2025. The number of employees decreased by 29 or -3.46% compared to the previous year.
Employees
808
Change (1Y)
-29
Growth (1Y)
-3.46%
Revenue / Employee
$518,106
Profits / Employee
$60,121
Market Cap
629.92M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 808 | -29 | -3.46% |
| Dec 31, 2024 | 837 | -58 | -6.48% |
| Dec 31, 2023 | 895 | 28 | 3.23% |
| Dec 31, 2022 | 867 | 56 | 6.91% |
| Dec 31, 2021 | 811 | 76 | 10.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ProKidney | 204 |
| Prime Medicine | 146 |
| Alpha Tau Medical | 125 |
| Annexon | 99 |
| Tectonic Therapeutic | 60 |
| AgomAb Therapeutics NV | 58 |
| Jade Biosciences | 55 |
| Design Therapeutics | 54 |
MDXG News
- 13 days ago - MIMEDX Expands Surgical Product Portfolio with the Launch of AMNIOFIX® Thyroid Shields - GlobeNewsWire
- 21 days ago - MiMedx Group, Inc. (MDXG) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 21 days ago - MIMEDX Announces Record Fourth Quarter and Full Year 2025 Operating and Financial Results - GlobeNewsWire
- 4 weeks ago - MIMEDX to Host Fourth Quarter and Full Year 2025 Operating and Financial Results Conference Call on February 25 - GlobeNewsWire
- 6 weeks ago - MIMEDX Enters into Exclusive Distribution Agreement with Summit Products Group for Multiple Innovative Surgical & Wound Products - GlobeNewsWire
- 6 weeks ago - MIMEDX Celebrates 15 Year Anniversary of EPIFIX® and AMNIOFIX® - GlobeNewsWire
- 3 months ago - MIMEDX Enters into Exclusive U.S. Distribution Agreement for RegenKit®-Wound Gel - GlobeNewsWire
- 4 months ago - MIMEDX Provides Update on EPIEFFECT® Randomized Controlled Trial - GlobeNewsWire